chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Left arm swollen, red x 2 days, worsening. Redness all around the left arm and swelling worsening and is getting tight. Tenderness to palpation present, edema present. Sent to hospital and was admitted for IV antibiotics every 6 hours for 24 hours. Discharged 9/16 and sent home on clindamycin for 10 days.
Initial unsolicited report received from a nurse on 29-Jul-2016. This case involves a female (age not reported) patient who was vaccinated with a dose of DTaP vaccine (Lot number C4709AA, expiry date, dose and route of administration were not reported) in left leg, IPV (Lot number M1453, expiry date, dose and route of administration were not reported) in right leg, MMR (manufacturer Merck, Lot number M002418, expiry date, dose and route of administration were not reported) on left leg, and Varicella (manufacturer Merck, Lot number M002062, expiry date, dose and route of administration were not reported) on right leg on an unspecified date. The patient's medical history and concomitant medications were not reported. On an unspecified date, following vaccination, the patient developed fever. It was reported that one day later, the fever was 103.5 - 104.7 degree Fahrenheit. Other Laboratory investigations and corrective treatment were not reported. The outcome of the event was not reported. List of documents held by sender: none.
Unconsolable crying different from his usual cry beginning 3 hours post vax and lasting for 3-4 hours.
RSV vaccine is indicated for age 60 and over. Patient was age 58 at time of vaccine.
- My normal fatigue has grown worse - My ability to concentrate has decreased - Itchy throat and cough from August 2021 - Present - I have more brain fog than I did before getting the vaccine, and it's been getting progressively worse this year - My libido has decreased - I've also noticed more heart palpitations and anxiety. My Apple Watch trends show that my resting heart rate has increased by 4bpm since vaccination. I'm unsure of if any of this is related.
within 2 days of the vaccine he began to feel dizzy, this progressed. he was admitted to hospital 2/1 and was found to have lacunar infarct as well as chronic cholecystitis as well as hypereosinophilia with AEC 4500-11000. no rash or renal failure. he had transamintiis that resolved with treatment of cholecystitis (percutaneous cholecystectomy). eosinophilia work up not yet completed at the time of this report.
Rash at site of the vaccine 4 days after vaccine administration. Flesh colored papules 4 x 7 cm.
where flu & pneumonia arm swelled, got red & hot, felt sick, chills, felt awful;next day worse-arm redder-swelling inc to 6" hurt on inside of arm & chest wall, fever 101.1, h/a, pain;all joint hurt,sleep in 2hr stretches;diarrhea;
Patient called pharmacy on 10/28/05 around 11 am, said that her right arm hurts a lot and its very difficult to move above head (right arm being site of injection on 10/21/05). She stated that the pain started 10/22/05 but its worse now.
Sharp, electrical shock pain on the R mammal area; This spontaneous case was reported by a consumer and describes the occurrence of BREAST PAIN (Sharp, electrical shock pain on the R mammal area) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008B21A) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension. Concomitant products included CELECOXIB (CELEBREX) for Antiinflammatory therapy, TRAMADOL and VITAMINS NOS for an unknown indication.    On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Mar-2021 at 11:00 PM, the patient experienced BREAST PAIN (Sharp, electrical shock pain on the R mammal area). At the time of the report, BREAST PAIN (Sharp, electrical shock pain on the R mammal area) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Most recent FOLLOW-UP information incorporated above includes: On 29-Mar-2021: The reporter has no further information about the case.
12/11/07 315p.m. Patient given Pneumovax (L) upper arm s.q. Developed pain and swelling (L) elbow. increased 12/12/07. Swelling, redness for 5 days, intense headache first 2 days; continued soreness.
RN administered 0.5 mL of the COVID-19 vaccine instead of 0.3 mL. No adverse reactions were documented.
I woke up 2 days later to my lymph nodes from my collar bone to under my armpit are very swollen.  My urine was very strong and pins and needles feeling in my stomach and kidney area. My muscles are extremely sore and feel very nauseated.  Had a headache the first day and a sore arm where the injection was made.
This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a patient of unknown gender and age. No information was provided regarding concomitant medications, concurrent conditions or medical history. The patient was prescribed the ZOSTAVAX vaccine by a healthcare provider for the long-term prevention of shingles and zoster-related conditions. On or about 11-DEC-2012, the patient was administered the ZOSTAVAX vaccine (strength, dose, frequency, route, lot# and expiration date were unknown). The patient was treated by a physician for the following injuries resulting from the patient's ZOSTAVAX use: Herpes zoster. The patient claimed damages as a result of: Injury to themselves; Loss of consortium; Loss of services; Economic losses. The following claims were asserted: negligence; products liability - defective design; products liability - manufacturing defect; products liability-failure to warn; breach of express warranty; breach of implied warranty; fraudulent misrepresentation; fraudulent concealment; negligent misrepresentation; unjust enrichment; strict liability; consumer fraud; loss of consortium; punitive damages. The outcome of the events was unknown. Causality assessments were related.
Patient received vaccine left exam room was standing at checkout window when fainted and fell backwards. Patient became very pale and diaphoretic and related to this and trauma cet transported to hospital.
Administer expired vaccine to patient, after the manufacture date of expiration; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administer expired vaccine to patient, after the manufacture date of expiration) in a 34-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048C21A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 10-Nov-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administer expired vaccine to patient, after the manufacture date of expiration). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Administer expired vaccine to patient, after the manufacture date of expiration) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant product use was reported.  Date the vial was initially stored in the refrigerator reported as unknown. Number of doses/vials was reported as 168 doses. The vial did not undergo any temperature excursions.  No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 08-Jun-2022: Follow up received contains non-significant information.
Patient has been running a fever up to 104, dizziness, shakes, muscle ache, headache, weakness, coughing, flush and loss of energy. These symptoms have been present 12 hours after injections and still are present(48 hours later)  Treatment has been extra fluids, advil, tylenol and nebulizer treatment.
Vaccine administered out of recommended time frame.  Administration occurred 14 days after 1st dose
She does have cardiac, kidney and spinal issues; She does have cardiac, kidney and spinal issues; She does have cardiac, kidney and spinal issues; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program.  A 6 year-old female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 2, single and administration date 2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: CARDIAC DISORDER (non-serious), RENAL DISORDER (non-serious), SPINAL DISORDER (non-serious), outcome "unknown" and all described as "She does have cardiac, kidney and spinal issues". Additional information: The patient was asking if there was going to be a booster soon for 5-11 year old.Their 06-year-old had taken both doses. The patient does had cardiac, kidney and spinal issues. They live in withheld and vaccine rates are low. Nobody wears masks at the patient school or anywhere there. They do wear mask. They need a booster to keep her safe Or a third dose. It was approaching 4 months since her 1st dose. I am concerned. Please authorize a third Shot or Booster. Thank You The lot number for bnt162b2 was not provided and will be requested during follow up.
perforation in my small intestine; shingles; pain; nerve damage; This case was reported by a consumer via media  and described the occurrence of intestinal perforation in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced intestinal perforation (serious criteria GSK medically significant), shingles, pain and nerve damage. The patient was treated with steroids nos (Steroids). On an unknown date, the outcome of the intestinal perforation, shingles, pain and nerve damage were unknown.   It was unknown if the reporter considered the intestinal perforation, shingles, pain and nerve damage to be related to Shingles vaccine.  Additional details were reported as follows: The case was reported by the patient. The age at vaccination was not reported. The patient had Shingles this summer from the date of reporting.  The steroids used to treat them caused a perforation in small intestine. Unspecified Steroids used for treatment were also considered as suspect for intestinal perforation. The pain was unbearable and at the time of reporting the patient had nerve damage.  The patient could get the vaccine in 6 month but the patient had one shot before and was not told to get a 2nd shot of vaccine. No contact details were reported.
Severe migraine which lasted for 4 weeks; unable to move around; heart rate increase quickly; inflammatory response to the vaccine; Pain; This is a spontaneous report from a contactable consumer (patient). A 40-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EW0175), via an unspecified route of administration, administered in the left arm on 17May2021 10:15 (at the age of 40 years old) as dose 2, single for COVID-19 immunization. Medical history included hypothyroid, migraine, celiac, gluten allergy, dairy allergy, nickel allergy and phenylephrine allergy, all from an unknown date and unknown if ongoing. The patient is not pregnant. The patient was taking unspecified concomitant medications in two weeks. The patient previously received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EW0175), via an unspecified route of administration, administered in the left arm on 25Apr2021 (at the age of 40 years old) as dose 1, single for COVID-19 immunization. The patient experienced severe migraine which lasted for 4 weeks, unable to move around, heart rate increase quickly, inflammatory response to the vaccine and pain on 22May2021. It was reported that 5 days after 2nd shot, the patient experienced severe migraine which lasted for 4 weeks and not reactive to treatment. During this time, the patient was unable to move around as it would make her heart rate increase quickly. Saw doctor, was assessed for stroke risk, and was told she was having an inflammatory response to the vaccine. Took large doses of ibuprofen for the last 2 weeks which helped reduce the pain. The events resulted in physician office visit. The patient has not had COVID prior vaccination and not COVID tested post vaccination. The patient underwent lab tests and procedures which included heart rate: increase on 22May2021. The outcome of all events was recovered on an unspecified date in 2021. No follow-up attempts are needed. No further information is expected.
2/23/21 itchy rash across upper back; 2/26/21 itchy, burning rash on entire back. spoke with PCP, triamcinolone cream started with mild relief. 2/28/21 rash on back no change, mild HA, chills, night sweats, daytime fatigue. 3/2/21 negative covid test, itchy rash continues, extended to upper thighs. 3/7/21 decreased energy, itchy rash, chills, daytime fatigue. 3/10/21 Itchy rash, chills, Dizzy when getting  OOB. 3/12/21 I cancelled 2nd dose.
gut pain; headache; cramping; diarrhea/7 bouts of diarrhea over 3 hours; facial flushing; This is a spontaneous report from contactable nurse.  A 58-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EK5730), via an unspecified route of administration, at the left arm on 19Dec2020 10:30 at a single dose for COVID-19 immunization at a hospital.  Medical history included hypertension and obesity. The patient has no known allergies. The patient was not tested for it since the vaccination. The patient's concomitant medications were not reported.  Adverse event: On 21Dec2020, 12:00, patient experienced gut pain, headache, cramping, 7 bouts of diarrhea over 3 hours, and 3/7 also coincided with facial flushing with no treatment. The patient did not recover from the events.
low grade fever; vertigo; This is a follow-up spontaneous from a contactable Physician. This Physician reported for a 93-year-old female consumer (patient). A 93-year-old female patient bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot number and Expiry date: not reported), dose 1 via an unspecified route of administration, on 05May2021, as single for COVID-19 immunization. The patient history included COVID-19 in Jan2021. The concomitant medications were not reported. On an unknown date in May2021, the patient had low grade fever and vertigo. She was feeling back into normal in about 48 hours. The patient was reluctant to take second dose of vaccine. The reporter would like to know if his mom should get second dose and what the efficacy of only one dose. The outcome of the events were recovered on an unknown date in May2021.  Information on the lot/batch number has been requested.
pt recvd 1st dose of Hep B FEB89 & later exp. h/a & pain in carpals w/ limited range  of motion;p/ pain in neck,arm;rx for arthritis
Severe joint pain in ankles, knees, elbows, and feet.  Swelling under the skin causing several red lumps and bruising along both legs and on feet.  Two lumps on elbows.  Low fever with night sweats.  Substantial pain in feet that feels like walking on rocks without shoes.  Symptoms vary in severity but have continued for four weeks.
This spontaneous report as received from a medical assistant refers to an unspecified number of patients of unknown age and gender. There was no information about the patients' concurrent conditions, concomitant therapies or medical histories provided. On an unknown dates, the patients were vaccinated with an improperly stored dose of VARIVAX (lot# K011081 with expiration date 08-AUG-2016; lot# L020002 with expiration date 02-JUN-2017; lot# L028276 with expiration date 28-JUL-2017; lot# L002216 with expiration date 21-JAN-2017; dose, anatomical location and route of administration were not reported). The vaccines were exposed to 4 hours 30 minutes at 47.5 Fahrenheit (F) on the fifth of April (year unspecified), 1 hour 30 minutes at 51.3 F, 2 hours at 56.3 F, 30 minutes at 6.1 F on the seventh of April (year unspecified) 1 hour and 30 minutes at 48.9 F on the fifth of May (year unspecified) and 1 hours at 51.6 F on the sixth of May (year unspecified). No adverse events were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Headache, lethargy, loss of appetite, fatigue, vesicular eruptions on face, pain, parasthesia, itching, mild aching from eye, ear and mastoid area.
Swelling/pain/pruritus at injection site, associated rise in BP to 166/100; advised by her Dr. to take BENADRYL and apply ice to site.
Incorrect vaccine administered to patient, Hep A was given instead of the Hep B that was ordered.
very dry and itchy eyes, slightly painful to open; very dry and itchy eyes, slightly painful to open; very dry and itchy eyes, slightly painful to open; This is a spontaneous report from a non-contactable consumer (patient). A 43-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; Lot Number: EN6202), via an unspecified route of administration, administered in left arm on 06Mar2021 15:45 (at the age of 43-years-old) as dose 1, single for COVID-19 immunization. Medical history included sleep apnea, and garlic and onion intolerance, from an unknown date and unknown if ongoing. There were no concomitant medications. The patient did not have any other vaccine in four weeks and no other medications in two weeks. The patient previously took Versed and experienced an adverse reaction of allergies. The patient reported that he woke up the next day with very dry and itchy eyes, slightly painful to open on 07Mar2021. The dry/itchy eyes lasted for about 8 hours. No treatment was received for the events. The patient has not been tested for COVID post-vaccination. Outcome of the events was recovered on 07Mar2021.   No follow-up attempts are possible. No further information is expected.
I had severe ringing in both ears that was extreme for 5 days.  I had pain in the arm that lasted 3-4 days and a feeling of being run down and slight cognitive degradation lasting 1-2 days.
Approximately 14 minutes post vaccination  -- developed numbness and tingling in L arm and "swelling" in throat.  Denies antecedent illness, allergies, medication use. Member was observed for 1 hr and 45 minutes.  No dyspnea, wheezing or chest pain.  BP 142/100, P 98, SpO2 98% on RA.  Released to home  after symptoms largely resolved.
Hive on left deltoid area after receiving PREVNAR 13 and Varicella #1. Pt. given dose of BENADRYL in office.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Nurse). The reporter is the patient.  A 52-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 11Sep2022 as dose 4 (booster), single (Lot number: GH9702) at the age of 51 years, in left arm for covid-19 immunisation; BNT162b2 (BNT162B2), on 17Dec2020 as dose 1, single (Lot number: EK5730), in left arm, on 12Jan2021 as dose 2, single (Lot number: EJ1686), in left arm and on 28Sep2021 as dose 3 (booster), single (Lot number: FC3592), in left arm for covid-19 immunisation. The patient's relevant medical history included: "Known allergies: Sulfa based medications" (unspecified if ongoing), notes: Sulfa based medications. Concomitant medication(s) included: OMEPRAZOLE, start date: 12May2022; CLARITIN [CLARITHROMYCIN]; ESTROGEN. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive, notes: Retested and was positive again. Therapeutic measures were taken as a result of vaccination failure, covid-19. Clinical course: Rebound covid symptoms starting 08Dec2022, 4 days after finishing round of Paxlovid. Retested and was positive again.; Sender's Comments: The vaccine efficacy varies from one patient to another and can be affected by different factors; however, a contributory role of the suspect vaccine BNT162B2 to the "Vaccination failure (LOE) and COVID-19" cannot be ruled out.
This spontaneous report as received from a nurse refers to an unspecified number of patients of unknown age and gender. On unspecified dates approximately in 2015, patients may have received doses of VAQTA lot # K005958, expiration date 09-FEB-2017 and lot # reported as K019560, expiration date: 02-JUN-2017 (dose and route of administration were not reported) which were improperly stored at 12.9 Celsius degree for 90 hours on unspecified dates during the time frame of April 2015 to May 2015. There was no known adverse effects. This is one of several reports received from the same reporter. Additional information has been requested.
After receiving my second shot my period started over a week early, lasting longer than normal, more spotting than normal and I was having symptoms of PMS which is not normal for me. It took about 3 months for my period to become regular for me again. After getting my 3rd shot I started spotting within 2 days of the shot and my period started over a week early again.
Chief Complaint Patient presents with ? Cough     seen at pcp about 1 week - diagnosed with sinus infection. given amoxicillin. sxs not getting any better since.  ? Fatigue ? Nasal Congestion
Patient was seen at Urgent Care clinic. Patient stated he was released and treated for bronchitis. Pending additional documentation from the facility.
Saw patient 6/30/04. Allergy reaction to probably Hib: rash on arms, legs, face. Started on 6/24/04. Red bumps with white spots liquid inside, fever, left eye swollen/ red. Mom stated pt had a rash not as severe after 5/5/04 immunizations Never saw child for that rash. Referred to allergist.
Twelve hours s/p vaccination developed fatigue. Twenty six hours s/p vaccination chills and fever started followed by muscle aches and stiffness. Thirty hours s/p vaccination  visibly swollen lymph nodes developed in right armpit. Fever persisted and red rash developed over trunk of body. Symptoms persisted until the morning of 10/13/21, approximately sixty six hours s/p vaccination. Symptoms were significantly worse compared to the second dose of vaccine when the only side effect experienced was fatigue.
Red arm red, swollen, hot from shoulder to elbow. Pneumonia shot.  Contacted by phone 11/27/06 took BENADRYL-Improved by Friday 11/24/2006.
Slight tenderness at injection site. Approximately 19 hours after booster, my hands, feet, and nose were cold and I could not warm then. Approximately 21.5 hours after booster, I went home and got into bed under several blankets. Two hours worth of shivering until I finally felt warm. One hour later, I needed to use the restroom and took my temperature. It was 102.5 but I attribute that number to being under several blankets. Took temperature one hour later just sitting in bed without all the blankets. Temperature was 101.9. Took 3 500 mg acetaminophen and temperature went down to 101.1 after approximately 20 minutes. Headache along frontal lobe Racing heart before standing, while standing going to restroom.
I received the vaccine Tuesday and had bad night sweats that night. I worked Wednesday with no issue. This morning (Thursday) I woke up with swollen and red eye lids. After Benadryl some swelling went down but still very red and painful. Temp was 99 at the last check.